BEYOND AIR INC. O.N. logo

BEYOND AIR INC. O.N.

Stock
Stock
Ticker: XAIR
XAIR

Price

Price

CHART BY

Frequently asked questions

The market capitalization of BEYOND AIR INC. O.N. is $3.02M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
BEYOND AIR INC. O.N.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$68.49. EPS indicates the company's profitability on a per-share basis.
Currently, 3 analysts cover BEYOND AIR INC. O.N.'s stock, with a consensus target price of $18.33. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, BEYOND AIR INC. O.N. reported a revenue of $7.69M.
BEYOND AIR INC. O.N.'s Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$24.40M. EBITDA measures the company's overall financial performance.
BEYOND AIR INC. O.N. has a free cash flow of -$19.60M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
BEYOND AIR INC. O.N. employs approximately 54 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of BEYOND AIR INC. O.N. is 984.41K. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$3.02M
EPS (TTM) 
-$68.49
Free Float 
984.41K
Revenue (TTM) 
$7.69M
EBITDA (TTM) 
-$24.40M
Free Cashflow (TTM) 
-$19.60M

Pricing

52W span
$3.07$55.20

Analyst Ratings

The price target is $18.33 and the stock is covered by 3 analysts.

Buy

3

Hold

0

Sell

0

Information

Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air, Beyond Cancer segments, and NeuroNos. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.

Employees
54
Industries
Medical Specialties
Sector
Health Care

Identifier

Primary Ticker
XAIR
Fundamentals & EOD data from FactSet
Join the conversation